Peptide-based tumor inhibitor encoding mitochondrial p14(ARF) is highly efficacious to diverse tumors.

Saito, Ken; Iioka, Hidekazu; Kojima, Chie; Ogawa, Mikako; Kondo, Eisaku

Saito, Ken; Iioka, Hidekazu; Kojima, Chie; Ogawa, Mikako; Kondo, Eisaku.

Affiliation

Saito K; Division of Molecular and Cellular Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Iioka H; Division of Molecular and Cellular Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Kojima C; Department of Applied Chemistry, Graduate School of Engineering, Osaka Prefecture University, Osaka, Japan.
Ogawa M; Laboratory of Bioanalysis and Molecular Imaging, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Kondo E; Division of Molecular and Cellular Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan. ekondo@med.niigata-u.ac.jp.

Cancer Sci ; 107(9): 1290-301, 2016 Sep.

Article de En | MEDLINE | ID: mdl-27317619

Sujet(s)
Mots clés

Mitochondria; p14; peptide; therapeutics; tumor suppressor

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Peptides / Protéine p14(ARF) suppresseur de tumeur / Antinéoplasiques Limites: Animals / Humans Langue: En Journal: Cancer Sci Année: 2016 Type de document: Article Pays d'affiliation: Japon

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google